Studies have found greater rates of temporal lobe atrophy in AD patients with greater load of E4 allele [6], [15]–[17] and reduced medial temporal lobe volumes in healthy ApoE4 carriers across the age spectrum [14], [18]–[21]. This evidence concerns the gene APOE and Alzheimer disease.